Cargando…

Endosialin-expressing bone sarcoma stem-like cells are highly tumor-initiating and invasive

It has been reported that the presence of a small group of cancer stem-like 'side population (SP)' cells is responsible for therapy failure and tumor recurrence. The present study demonstrated that primary human osteosarcoma samples contained a SP of about 3.9% which overexpressed ABC tran...

Descripción completa

Detalles Bibliográficos
Autores principales:	SUN, DONG-XIU, LIAO, GUANG-JUN, LIU, KE-GUI, JIAN, HAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581793/ https://www.ncbi.nlm.nih.gov/pubmed/26300407 http://dx.doi.org/10.3892/mmr.2015.4218

Ejemplares similares

Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies
por: O'Shannessy, Daniel J., et al.
Publicado: (2016)

Endosialin defines human stem Leydig cells with regenerative potential
por: Xia, Kai, et al.
Publicado: (2020)

Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells
por: Thway, Khin, et al.
Publicado: (2016)

Characterization of TEM1/endosialin in human and murine brain tumors
por: Carson-Walter, Eleanor B, et al.
Publicado: (2009)

Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma
por: Capone, Emily, et al.
Publicado: (2017)

Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications
por: Kiyohara, Eiji, et al.
Publicado: (2015)

Novel antibody probes for the characterization of endosialin/TEM-1
por: O'shannessy, Daniel J., et al.
Publicado: (2016)

Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma
por: Kondo, Yumiko, et al.
Publicado: (2022)

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature
por: Rybinski, Katherine, et al.
Publicado: (2015)

Development of (89)Zr-Ontuxizumab for in vivo TEM-1/endosialin PET applications
por: Lange, Sara E.S., et al.
Publicado: (2016)

Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2
por: Ohradanova, A, et al.
Publicado: (2008)

A Differential Role for CD248 (Endosialin) in PDGF-Mediated Skeletal Muscle Angiogenesis
por: Naylor, Amy J., et al.
Publicado: (2014)

Hepatic stellate cells limit hepatocellular carcinoma progression through the orphan receptor endosialin
por: Mogler, Carolin, et al.
Publicado: (2017)

No Significant Association Between Plasma Endosialin Levels and the Presence or Severity of Coronary Artery Disease
por: Kishimoto, Yoshimi, et al.
Publicado: (2022)

Influence of tumor microenvironment on prognosis in colorectal cancer: Tissue architecture-dependent signature of endosialin (TEM-1) and associated proteins
por: O'Shannessy, Daniel J., et al.
Publicado: (2014)

A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors
por: Doi, Toshihiko, et al.
Publicado: (2019)

Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Hepatic stellate cell-expressed endosialin balances fibrogenesis and hepatocyte proliferation during liver damage
por: Mogler, Carolin, et al.
Publicado: (2015)

Correction to: Endosialin‑positive tumor‑derived pericytes promote tumor progression through impeding the infiltration of CD8(+) T cells in clear cell renal cell carcinoma
por: Lu, Tong, et al.
Publicado: (2023)

Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas
por: Murase, M, et al.
Publicado: (2009)

Genetic Deletion of the Stromal Cell Marker CD248 (Endosialin) Protects against the Development of Renal Fibrosis
por: Smith, Stuart William, et al.
Publicado: (2016)

Preclinical Evaluation and Dosimetry of [(111)In]CHX-DTPA-scFv78-Fc Targeting Endosialin/Tumor Endothelial Marker 1 (TEM1)
por: Cicone, Francesco, et al.
Publicado: (2020)

Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy
por: Zhang, Zhi-Yong, et al.
Publicado: (2011)

Hypoxia-inducible Factor may Induce the Development of Liver Fibrosis in Budd–Chiari Syndrome by Regulating CD248/endosialin Expression: A Hypothesis
por: Tian, Ye, et al.
Publicado: (2018)

Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer—A Preliminary Study
por: Pietrzyk, Łukasz, et al.
Publicado: (2020)

HCV and tumor-initiating stem-like cells
por: Machida, Keigo
Publicado: (2022)

CD248/endosialin critically regulates hepatic stellate cell proliferation during chronic liver injury via a PDGF-regulated mechanism
por: Wilhelm, Annika, et al.
Publicado: (2016)

Synovial sarcoma of bone: Sarcoma typically of soft tissues presenting as a primary bone tumor
por: Caracciolo, Jamie T., et al.
Publicado: (2018)

Temporal Bone Myeloid Sarcoma
por: Chang, Ki-Hong, et al.
Publicado: (2009)

Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells
por: Fujiwara, Tomohiro, et al.
Publicado: (2016)

SYT-SSX1 enhances the invasiveness and maintains stem-like cell properties in synovial sarcoma via induction of TGF-β1/Smad signaling
por: Qi, Yan, et al.
Publicado: (2022)

Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells
por: Machida, Keigo, et al.
Publicado: (2022)

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
por: Han, Dan, et al.
Publicado: (2019)

Bone marrow mesenchymal stem cell-derived exosomal LINC00847 inhibits the proliferation, migration, and invasion of Ewing sarcoma
por: Huang, Lu, et al.
Publicado: (2022)

Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone Sarcoma
por: Lawrenz, Joshua M., et al.
Publicado: (2020)

Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor‐Initiating Stem‐Like Cells
por: Chen, Chia‐Lin, et al.
Publicado: (2023)

Risk factors of regional lymph node (RLN) metastasis among patients with bone sarcoma and survival of patients with RLN-positive bone sarcoma
por: Dong, Yimin, et al.
Publicado: (2021)

Modeling the Initiation of Ewing Sarcoma Tumorigenesis in Differentiating Human Embryonic Stem Cells
por: Gordon, David J., et al.
Publicado: (2015)

Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas
por: Menéndez, Sofía T., et al.
Publicado: (2021)

Adult Primary Bone Sarcoma and Time to Treatment Initiation: An Analysis of the National Cancer Database
por: Lawrenz, Joshua M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sci8qd2ktmm2kgf537cuf943is